drugset / Trial / NCT00904800
AZD0837 Extended Release (ER) Japan Study
RandomizedParallel-groupSingle-blindBasic science
Summary
This phase I study will evaluate safety and tolerability after repeated doses of AZD0837.
Timeline
- Start
- 2009-05
- Primary completion
- —
- Completion
- 2009-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ATECEGATRAN METOXIL | Small molecule | — | Oral |
Indications
No indication recorded.